CN Stock MarketDetailed Quotes

Vcanbio Cell & Gene Engineering Corp.,Ltd. (600645)

Watchlist
  • 23.05
  • -0.39-1.66%
Trading May 15 09:52 CST
10.79BMarket Cap98.09P/E (TTM)

Vcanbio Cell & Gene Engineering Corp.,Ltd. (600645) Key Financial Indicators

600645 Earnings per Share (EPS)

According to the latest financial report of Vcanbio Cell & Gene Engineering Corp.,Ltd., the latest earnings per share (TTM) for the company is 0.05. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

Loading...

600645 Book Value Per Share (BVPS)

Analyzing a company's fundamentals? Check out Vcanbio Cell & Gene Engineering Corp.,Ltd.'s latest financial report to see how much their book value per share (BVPS) is currently at 7.95.

Currency: CNY

Cumulative Quarterly

Loading...

600645 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Vcanbio Cell & Gene Engineering Corp.,Ltd. shows that the company's current ratio is 1.88, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Loading...

600645 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Vcanbio Cell & Gene Engineering Corp.,Ltd., the quick ratio is 1.72, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

Loading...

600645 Return on Equity (ROE)

Want to learn more about the financial health of Vcanbio Cell & Gene Engineering Corp.,Ltd.? The latest ROE figure is 0.65%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

Loading...

600645 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Vcanbio Cell & Gene Engineering Corp.,Ltd., the total asset return on investment (ROA) is 0.46%.

Currency: CNY

Cumulative Quarterly

Loading...

600645 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Vcanbio Cell & Gene Engineering Corp.,Ltd.'s latest financial report to see how their gross margin is doing - currently at 69.57%.

Currency: CNY

Cumulative Quarterly

Loading...

600645 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Vcanbio Cell & Gene Engineering Corp.,Ltd., the net profit margin is 7.61%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More